Literature DB >> 18359981

The proteome profile of the human osteosarcoma U2OS cell line.

Katerina M Niforou1, Athanasios K Anagnostopoulos, Konstantinos Vougas, Christos Kittas, Vassilis G Gorgoulis, George T Tsangaris.   

Abstract

The human osteosarcoma U2OS cell line is one of the first generated cell lines and is used in various areas of biomedical research. Knowledge of its protein expression is limited and no comprehensive study on the proteome of this cell line has been reported to date. Proteomics technology was used in order to analyse the proteins of the U2OS cell line. Total protein extracts were separated by two-dimensional gel electrophoresis (2-DE) and analysed by matrix-assisted laser desorption ionisation-mass spectrometry (MALDI-MS) and MALDI--MS-MS following in-gel digestion with trypsin and, finally, protein identification was carried out by peptide mass fingerprint (PMF) and post source decay (PSD), respectively. Approximately 3,000 spots were excised from two 2-DE gels and were analysed, resulting in the identification of 237 different gene products. The majority of the identified proteins were enzymes, regulatory proteins and RNA-associated proteins, while leukocyte markers and oncogenes were also present. Our findings include 11 protooncogenes (FKBP4, SRC8, PSD10, FUBP1, PARK7, NPM, PDIA1, OXRP, SET, TCTP and GRP75) related to the cancerous state of the U2OS cell line. The U2OS 2-DE database provides the basis for future protein studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359981

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  24 in total

1.  Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane.

Authors:  Maurice Balke; Anna Neumann; Christian Kersting; Konstantin Agelopoulos; Carsten Gebert; Georg Gosheger; Horst Buerger; Martin Hagedorn
Journal:  BMC Res Notes       Date:  2010-03-04

2.  Split and Merge Watershed: a two-step method for cell segmentation in fluorescence microscopy images.

Authors:  Margarita Gamarra; Eduardo Zurek; Hugo Jair Escalante; Leidy Hurtado; Homero San-Juan-Vergara
Journal:  Biomed Signal Process Control       Date:  2019-06-04       Impact factor: 3.880

3.  Runx2 expression: A mesenchymal stem marker for cancer.

Authors:  Maria Teresa Valenti; Paola Serafini; Giulio Innamorati; Anna Gili; Samuele Cheri; Claudio Bassi; Luca Dalle Carbonare
Journal:  Oncol Lett       Date:  2016-09-23       Impact factor: 2.967

Review 4.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

5.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

6.  Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.

Authors:  Zhiyu Zhang; Lijun Zhang; Yingqi Hua; Xiaofang Jia; Jian Li; Shuo Hu; Xia Peng; Pengyuan Yang; Mengxiong Sun; Fang Ma; Zhengdong Cai
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

Review 7.  Far upstream element binding protein 1: a commander of transcription, translation and beyond.

Authors:  J Zhang; Q M Chen
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

Review 8.  The master regulator FUBP1: its emerging role in normal cell function and malignant development.

Authors:  Lydie Debaize; Marie-Bérengère Troadec
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

9.  Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.

Authors:  Michalis Liontos; Katerina Niforou; Georgia Velimezi; Konstantinos Vougas; Konstantinos Evangelou; Kalliopi Apostolopoulou; Radek Vrtel; Alexandros Damalas; Panayiotis Kontovazenitis; Athanassios Kotsinas; Vassilis Zoumpourlis; George Th Tsangaris; Christos Kittas; Doron Ginsberg; Thanos D Halazonetis; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

10.  Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.

Authors:  Lei Yang; Jun-Ya Zhu; Jian-Guo Zhang; Bo-Jun Bao; Cheng-Qi Guan; Xiao-Jing Yang; Yan-Hua Liu; Yue-Jiao Huang; Run-Zhou Ni; Li-Li Ji
Journal:  Tumour Biol       Date:  2015-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.